Table 1.

Distributions of rheumatic diseases and therapies in 237 patients. Data are the mean ± SD or n (%).

Feature
Disease
  Juvenile systemic lupus erythematosus99 (41.8)
  Juvenile idiopathic arthritis93 (39.2)
  Juvenile dermatomyositis18 (7.6)
  Juvenile scleroderma11 (4.6)
  Primary vasculitis16 (6.8)
Treatment
  Prednisone90 (38)
    Dose, mg/day17.4 ± 14.2
    Dose, mg/kg/day0.36 ± 0.32
    Dose ≥ 20 mg/day36 (40)
    Duration of glucocorticoid therapy, mo43.1 ± 34.5
  Immunosuppressant143 (60.3)
    Methotrexate74 (51.7)
    Azathioprine43 (30.1)
    Cyclosporine23 (16.1)
    Mycophenolate mofetil13 (9.1)
    Leflunomide6 (4.2)
    Cyclophosphamide3 (2.1)